MORPHINE SULFATE ER 30 MG CAP

MORPHINE SULFATE
$3.3842per EA
DEA Schedule CII

Strength

30 mg/1

NDC

00115127801

Classification

Generic

Dosage Form

CAPSULE, EXTENDED RELEASE

Route

ORAL

Last Updated

1/19/2022

Active Ingredients

MORPHINE SULFATE

Approval Type

Generic (ANDA)

FDA Application

ANDA200411

On Market Since

4/12/2016

Pharmacological Classes

Full Opioid Agonists
Opioid Agonist

Price History

1W

0.0%

1M

0.0%

3M

0.0%

6M

0.0%

1Y

0.0%

3Y

0.0%

5Y

+29.1%

All

+13.5%